69P The diabetes drug canagliflozin sensitizes non-small cell lung cancer (NSCLC) to radiotherapy and chemotherapy Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Tsakiridis, T
  • Villani, L
  • Broadfield, L
  • Marcinko, K
  • Tsakiridis, E
  • Ellis, P
  • Muti, P
  • Steinberg, Gregory

publication date

  • April 2018